Normal view MARC view ISBD view

An approach on current regulatory considerations of adverse event reporting & pharmacovigilance for biologics in India and US

AGRAWAL, Ayushi

An approach on current regulatory considerations of adverse event reporting & pharmacovigilance for biologics in India and US - viii, 148

Print
Add to your cart (remove)
Send to device
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)